Study Enrollment


Your details will not be published or shared.

Clinical Trial

S1933, “A Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients with Borderline Performance Status”


Eligibility Criteria

  • Participants must be ? 18 years of age Non-Small Cell Lung Cancer (NSCLC) Stage II or III NSCLC

Contact Information

    Sandra Duncan

    (706) 721-5775

   sduncan@augusta.edu

RESEARCH. INNOVATION. DISCOVERY.